Herceptin

Active ingredient
Trastuzumab
Medical indication
Krebs
Pharma Company
Roche Pharma AG/ Roche Deutschland Holding GmbH
Total Number of Doctors1
1,004 doctors
Total Number of Patients2
5,936 patients
Total minimum fees planned3
1,105,350.00 €

Observational Studies including Herceptin

Drug No. of doctors1 No. of patients2 Payment per patient3
Herceptin 150 mg 199 239 650.00 € kein Honorar angegeben
Herceptin 150 mg 232 500 1,900.00 € max. pro Patient, aufgelistet im Vertrag
Herceptin n/a n/a n/a
Herceptin 73 1,197 n/a Erstanmeldung 2007 (Brief)
Herceptin 150 mg 500 4,000 n/a Meldung vor Anzeigenpflicht

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.